Pfizer CEO Albert Bourla on Saturday said people getting COVID-19 booster shots every four to five months is "not a good scenario" and argued that an annual vaccine would be a better approach to fighting the virus.



US & Canada

Vaccinations

Pfizer

North America

Health

Vaccines

Coronavirus

Pandemic

Washington DC

Washington

Yahoo News

Reuters

CTV News

Global News

CNBC

Pfizer CEO says frequent boosters 'not a good scenario,' hopes for yearly vaccine

I hope that we will manage to get to the point where we will be able to vaccinate regularly, once a year, said the head of the Pfizer concern Albert Bourla.

Do Rzeczy

Pfizer CEO: We should get vaccinated regularly, once a year

The research, published in the Journal of the American Medical Association, also found those who received the Moderna vaccine were less likely to be hospitalised, compared to recipients of the...

Moderna

Medical Dialogues

Moderna vax may  lead to fewer breakthrough Covid infections than Pfizer: study

New Delhi: Singapore will extend its Covid-19 booster vaccination programme to adolescents aged 12 to 17 years from next month, its health ministry said on Friday.Also Read:Pfizer COVID vaccine

New Delhi

Singapore approves Covid-19 vaccine boosters for age 12-17s

JERUSALEM - Pfizer Inc Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission. With cases

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

ORF.at News

Pfizer boss relies on annual vaccination

In the shadow of the rise in morbidity, Albert Burla was interviewed by "Weekend News" and said that the Corona is expected to stay with us in the coming years as well, but stressed: "Work on a vaccine before a new wave is formed"

mako

N12 - Pfizer CEO Albert Burla in a special interview

Pfizer (PFE) and Merck (MRK), the developers of the first oral medications for COVID-19 in the U.S., are advancing combination studies for their antiviral therapies as experts flag the...

Merck

Seeking Alpha

Pfizer, Merck trial antiviral combos amid concerns over resistance to COVID-19 pills

Feds

Politics

The Daily Caller

The Daily Wire

The Gateway Pundit

Freedom Rock Radio

‘Paramount importance’: Judge orders FDA to hasten release of Pfizer vaccine docs

Trending Stories

Trending Topics

Latest Stories

More Current Topics